[go: up one dir, main page]

CN110876817B - Porous PEEK (polyetheretherketone) bionic bone repair material, PEEK bionic bone part with multilayer structure and preparation method thereof - Google Patents

Porous PEEK (polyetheretherketone) bionic bone repair material, PEEK bionic bone part with multilayer structure and preparation method thereof Download PDF

Info

Publication number
CN110876817B
CN110876817B CN201910779682.3A CN201910779682A CN110876817B CN 110876817 B CN110876817 B CN 110876817B CN 201910779682 A CN201910779682 A CN 201910779682A CN 110876817 B CN110876817 B CN 110876817B
Authority
CN
China
Prior art keywords
peek
bone
layer
parts
raw material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201910779682.3A
Other languages
Chinese (zh)
Other versions
CN110876817A (en
Inventor
李凝
陈德强
胡礼广
林祝亮
刘露
李新辉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang Normal University CJNU
Original Assignee
Zhejiang Normal University CJNU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Normal University CJNU filed Critical Zhejiang Normal University CJNU
Priority to CN201910779682.3A priority Critical patent/CN110876817B/en
Publication of CN110876817A publication Critical patent/CN110876817A/en
Application granted granted Critical
Publication of CN110876817B publication Critical patent/CN110876817B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/025Other specific inorganic materials not covered by A61L27/04 - A61L27/12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/12Phosphorus-containing materials, e.g. apatite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3616Blood, e.g. platelet-rich plasma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3645Connective tissue
    • A61L27/365Bones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843Connective tissue
    • A61L27/3847Bones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/02Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Dispersion Chemistry (AREA)
  • Materials For Medical Uses (AREA)

Abstract

本发明公开了一种多孔PEEK仿生骨修复材料和具有多层结构的PEEK仿生骨制件及其制备方法。按质量份数计,该多孔PEEK仿生骨修复材料的原料组成包括基体材料100份、增强材料12‑16份、发泡剂0.1‑3份和生物活性物质0.1‑0.5份;基体材料包括质量比为14:1的PEEK粉末和PTFE粉末。本发明的PEEK仿生骨修复材料中采用发泡剂在基体材料中形成孔隙,与致孔剂的成孔机制不同,在形成孔隙后无须除去发泡剂,既简化了工艺,又节约了能源。并且,生物活性物质的添加将有效改善仿生材料与人体组织的生物相容性,提高人体自身原体液的生理活性,有利于激发细胞、组织、神经元在仿生体内的存活度,提高修复性能。

Figure 201910779682

The invention discloses a porous PEEK biomimetic bone repair material, a PEEK biomimetic bone product with a multi-layer structure and a preparation method thereof. In parts by mass, the raw material composition of the porous PEEK biomimetic bone repair material includes 100 parts of base material, 12-16 parts of reinforcing material, 0.1-3 parts of foaming agent and 0.1-0.5 part of biological active substance; the base material includes mass ratio 14:1 PEEK powder and PTFE powder. In the PEEK biomimetic bone repair material of the present invention, a foaming agent is used to form pores in the matrix material, which is different from the pore-forming mechanism of the porogen, and the foaming agent does not need to be removed after the pores are formed, which simplifies the process and saves energy. In addition, the addition of bioactive substances will effectively improve the biocompatibility of biomimetic materials with human tissues, improve the physiological activity of the human body's own original body fluid, and help stimulate the survival of cells, tissues and neurons in the bionic body and improve repair performance.

Figure 201910779682

Description

Porous PEEK (polyetheretherketone) bionic bone repair material, PEEK bionic bone part with multilayer structure and preparation method thereof
Technical Field
The invention belongs to the field of bionic bone materials, and particularly relates to a porous PEEK bionic bone repair material, a PEEK bionic bone part with a multilayer structure and a preparation method thereof.
Background
The repair of massive bone defects caused by factors such as trauma, infection, tumor excision and the like is a difficult problem faced by clinical medicine at home and abroad for a long time, and the repair materials of the massive bone defects mainly come from autogenous bone, artificial bone, organic glass, bone cement, silicon rubber, stainless steel, titanium mesh, polyether ether ketone (PEEK) and the like. Wherein, autologous bone sources are limited, and patients may need to suffer additional pain in order to obtain autologous bone; other bone repair materials not only easily cause potential infection, immunological rejection and other problems, but also can only play a part of the function replacement role.
PEEK is currently the repair material with a modulus of elasticity closest to that of human bone and is therefore the focus of current skull repair research. PEEK has characteristics such as good biocompatibility, excellent mechanical properties, light weight, and X-ray penetrability, and although PEEK itself has a defect of poor osseointegration, the osseointegration ability of PEEK can be moderately improved by attaching bioactive substances such as nano-hydroxyapatite, nano-titanium dioxide, calcium silicate, β -tricalcium phosphate, and bioactive glass to the surface of PEEK.
For example, the Chinese patent application with publication number CN108273137A discloses a porous bionic skull repairing material and a personalized manufacturing method, the porous bionic skull repairing material is matched with a human skull structure, the surface layer is a compact layer, the inner layer is a loose layer, the compact layer is bionic cortical bone, and the loose layer is a bionic skull trabecular structure. The porous bionic skull repairing material can be made into a porous bionic skull repairing prosthesis by adopting a mixed molding method, and the mixed molding method comprises the following steps: (1) scanning the skull of a patient by using a computed tomography technology, segmenting and extracting data by using image processing software, reconstructing a three-dimensional model of the skull and a defect part of the patient, and calculating the size and the curvature of the artificial skull of the defect part;
(2) Preparing a composite structure plate: firstly, mixed powder is prepared: adding polyaryletherketone materials, bioactive substances and pore-forming agents into a V-shaped mixer according to a certain proportion, and fully and uniformly mixing to respectively prepare powder materials of a compact layer and a loose layer; cold press molding: preparing mixed powder of a compact layer and a loose layer according to the ideal volume of a 102% mold: placing the powder of the dense layer and the powder of the loose layer prepared in the step I into a mould, placing the mould into a hydraulic press, compacting the materials at the pressure of 1-150MPa to prepare a plate, repeatedly pressurizing and releasing pressure for one or more times to completely discharge residual gas in the mould, maintaining the pressure for 1-60min, and ensuring the quality and the performance of the plate; melting: opening an external heating device for the pressed blank or the die obtained in the step two or putting the pressed blank or the die into a high-temperature oven, and melting and heating the plate, wherein the heating temperature is set to be between the melting point of the polyaryletherketone material and the melting point of the pore-forming agent; fourthly, hot-press forming: rapidly placing the melted blank obtained in the step (III) or placing the blank in a press, repeatedly pressurizing and releasing pressure once or for many times under the maximum pressure of 1-100MPa, maintaining the pressure for 10-60min, cooling the die at the speed of 40 ℃/min, placing the die into a demolding seat, demolding and taking out the blank;
(3) Shaping treatment: guiding the established three-dimensional model of the skull defect part of the patient into a die-free multipoint forming device, heating the blank obtained in the step (2) to a temperature between the plastic deformation temperature and the melting point temperature of the polyaryletherketone material, quickly moving the blank to the die-free multipoint forming device, performing compression forming to obtain a personalized skull repairing material customized according to the patient, and cutting the personalized skull repairing material into artificial skull with the size exceeding the calculated size by about 1 cm;
(4) preparing a skull repairing prosthesis with a porous bionic composite structure: and (4) placing the personalized skull repairing prosthesis obtained in the step (3) in an ultrasonic water bath kettle, a constant temperature oscillator or a salt bath kettle, setting the temperature to be 50-100 ℃, completely separating out a pore-forming agent, and then carrying out drying treatment (for about 24 hours) to obtain the porous bionic skull repairing prosthesis customized according to the patient.
The porous bionic skull repairing material has the following defects: the pore-foaming agent adopted in the preparation process is conventional inorganic salt, and the pore-foaming agent needs to be completely separated out and dried after compression molding, so that the time consumption is long and the energy consumption is large.
Disclosure of Invention
The invention aims to provide a porous PEEK bionic bone repair material, a PEEK bionic bone part with a multilayer structure and a preparation method thereof.
In order to achieve the above purpose, the technical solution of the present application is as follows:
a porous PEEK bionic bone repair material comprises, by mass, 100 parts of a base material, 12-16 parts of a reinforcing material, 0.1-3 parts of a foaming agent and 0.1-0.5 part of a bioactive substance;
the base material comprises PEEK powder and PTFE powder in a mass ratio of 14: 1.
According to the PEEK bionic bone repair material, the foaming agent is adopted to form pores in the base material, the pore-forming mechanism is different from that of a pore-forming agent, and the foaming agent does not need to be removed after the pores are formed, so that the process is simplified, and the energy is saved.
The addition of the bioactive substances can effectively improve the biocompatibility of the bionic material and human tissues, improve the physiological activity of the human body original body fluid, and is beneficial to exciting the survival degree of cells, tissues and neurons in the bionic body and improving the repair performance.
In the porous PEEK bionic bone repair material, the foaming agent is sodium bicarbonate and azodicarbonamide (namely foaming agent AC) in a mass ratio of 9: 1.
In the porous PEEK bionic bone repair material, the reinforcing material comprises silk fibroin modified nano-hydroxyapatite and sulfonated PEEK modified calcium carbonate whisker in a mass ratio of 3: 7.
The natural polymer silk fibroin has unique mechanical property, excellent biocompatibility, excellent moisture absorption and preservation and antimicrobial capability, and wide source, and the modification of the nano hydroxyapatite by utilizing the silk fibroin is expected to overcome the problem of insufficient mechanical property of pure hydroxyapatite, and is suitable for the repair and replacement of hard tissues, particularly loaded bones.
And the sulfonated PEEK is adopted to modify the surface of the calcium carbonate whisker, so that the aim of enhancing the compatibility between the surface of the calcium carbonate whisker and an organic material interface can be achieved, and the requirement on the mechanical property of the bionic material in a human body can be further met.
In the porous PEEK bionic bone repair material, the silk fibroin modified nano hydroxyapatite is obtained by soaking the nano hydroxyapatite in a silk fibroin solution with the concentration of 3% for 20-40 min;
the sulfonated PEEK modified calcium carbonate whisker is obtained by mixing and crosslinking calcium carbonate whisker and sulfonated PEEK in a mass ratio of 100:3, and the sulfonation degree of the sulfonated PEEK is 84.0-99.6%.
In the porous PEEK bionic bone repair material, the bioactive substances are as follows: serum containing 0.125% concentration of induction stock and plasma containing 1.8% concentration of mesenchymal stem cells;
The concentration of the inducing stock solution in serum is 0.12-0.14%, and the concentration of mesenchymal cells in plasma is 1.6-2.0%.
In the PEEK bionic bone part with the multilayer structure, each layer of structure is made of the porous PEEK bionic bone repair material, and the content of the foaming agent in the raw material composition of each layer of structure is gradually increased from the outer side to the center of the PEEK bionic bone part. The higher the content of foaming agent, the higher the porosity, so that the produced bionic bone is consistent with the human bone structure.
The porous PEEK bionic bone repair material can be prepared into various shapes of bionic bone parts and used for repairing bone structures of various parts of a human body.
As a specific embodiment, the PEEK bionic bone part with a multilayer structure of the invention is a human tibia bionic part, which sequentially comprises a periosteum layer, a compact bone layer, a loose bone layer and a medullary cavity from outside to inside, wherein the thickness of the periosteum layer is 0.2mm, the porosity of the compact bone layer is 10-15%, the porosity of the loose bone layer is 36-44%, and the diameter of the medullary cavity is 6-12 mm.
The raw materials of the periosteum layer comprise 100 parts of base material, 12-16 parts of reinforcing material, 0.1 part of foaming agent and 0.1-0.3 part of bioactive substance by weight;
The raw material composition of the bone dense layer comprises 100 parts of base material, 12-16 parts of reinforcing material, 0.5 part of foaming agent and 0.3-0.5 part of bioactive substance;
the raw material composition of the bone loose layer comprises 100 parts of matrix material, 12-16 parts of reinforcing material, 3 parts of foaming agent and 0.3-0.5 part of bioactive substance.
The preparation method of the PEEK bionic bone part with the multilayer structure comprises the following steps:
(1) adding PTFE powder and a reinforcing material into PEEK powder according to preset raw material composition, continuously stirring for 24 hours, adding a foaming agent, and continuously stirring for 1-2 hours to respectively obtain a periosteum layer raw material mixture, a compact bone layer raw material mixture and a bone loose layer raw material mixture;
(2) prefabricating a shin bone mold, preheating to 220 ℃, respectively adding the periosteum layer raw material mixture, the compact bone layer raw material mixture and the bone loose layer raw material mixture into corresponding mold cavities, then heating to 340-;
(3) placing the workpiece into a container at the temperature of 110-;
(4) putting the workpiece into flowing clear water for washing for 6-10h, taking out and drying;
(5) soaking the workpiece in serum containing an induction stock solution for 12h, taking out and drying;
(6) And (3) putting the part into plasma containing mesenchymal stem cells to be soaked for 2h to obtain the PEEK bionic bone part with the multilayer structure.
The invention also provides application of the PEEK bionic bone part with the multilayer structure in bone repair.
Compared with the prior art, the invention has the beneficial effects that:
(1) according to the PEEK bionic bone repair material, the foaming agent is adopted to form pores in the base material, the pore-forming mechanism is different from that of a pore-forming agent, and the foaming agent does not need to be removed after the pores are formed, so that the process is simplified, and the energy is saved.
(2) The addition of the bioactive substances can effectively improve the biocompatibility of the bionic material and human tissues, improve the physiological activity of the human body original body fluid, and is beneficial to exciting the survival degree of cells, tissues and neurons in the bionic body and improving the repair performance.
Drawings
FIG. 1 is a schematic structural diagram of a PEEK bionic bone part with a multilayer structure according to the present invention;
FIG. 2a is an electron microscope microscopic view of the periosteum layer of a PEEK biomimetic bone product with a multi-layer structure according to the present invention;
FIG. 2b is an electron microscope microscopic view of the dense bone layer of a PEEK biomimetic bone product with a multi-layer structure according to the present invention;
FIG. 2c is an electron microscope microscopic view of the bone cancellous layer of a PEEK biomimetic bone product with a multi-layered structure according to the present invention.
Detailed Description
The technical solution of the present invention will be further described in detail with reference to the accompanying drawings and the detailed description.
Example 1
The PEEK bionic bone part with the multilayer structure of the embodiment is a human tibia bionic part, and the structure of the PEEK bionic bone part is shown in fig. 1, and the PEEK bionic bone part sequentially comprises a periosteum layer 1, a bone dense layer 2, a bone loose layer 3 and a bone marrow cavity 4 from outside to inside, and is consistent with the structure of a human tibia.
The preparation method comprises the following steps:
(1) putting 28g of PEEK powder and 2g of PTFE powder into a container, adding 3.6g of calcium carbonate whiskers and 0.108g of sulfonated PEEK (the sulfonation degree is 84%) into the PEEK and PTFE powder, continuously stirring for 24h, adding 1.5g of silk fibroin modified hydroxyapatite, continuously stirring for 12h, adding 0.03g of sodium bicarbonate and 0.003g of azodicarbonamide, and continuously stirring for 30min to obtain an periosteum raw material mixture;
putting 28g of PEEK powder and 2g of PTFE powder into a container, adding 3.6g of calcium carbonate whiskers and 0.108g of sulfonated PEEK (the sulfonation degree is 84%) into the PEEK powder, continuously stirring for 24h, adding 1.5g of silk fibroin modified hydroxyapatite, continuously stirring for 12h, adding 0.09g of sodium bicarbonate and 0.01g of azodicarbonamide, and continuously stirring for 30min to obtain a raw material mixture of a compact bone layer;
28g of PEEK powder and 2g of PTFE powder are placed in a container, 3.6g of calcium carbonate whiskers and 0.108g of sulfonated PEEK (the sulfonation degree is 84%) are added into the PEEK powder, the mixture is continuously stirred for 24 hours, then 1.5g of silk fibroin modified hydroxyapatite is added, the mixture is continuously stirred for 12 hours, then 0.9g of sodium bicarbonate and 0.02g of azodicarbonamide are added, and the mixture is continuously stirred for 30 minutes to obtain a raw material mixture of a bone loose layer;
the silk fibroin modified hydroxyapatite is obtained by the following method: soaking nanometer hydroxyapatite in 3% silk fibroin solution for 30min, filtering, and oven drying at 80 deg.C.
(2) Respectively adding the periosteum layer raw material mixture, the compact bone layer raw material mixture and the bone loose layer raw material mixture into corresponding cavities of a 340-DEG C hot-pressing die, reacting for 15min under 25MPa, cooling the die to 160 ℃ by water, opening the die, and taking out a finished piece;
(3) putting the workpiece into a furnace, keeping the temperature at 110 ℃ for 10h, taking out the workpiece, and cooling the workpiece to room temperature;
(4) putting the workpiece into flowing clear water for washing for 6h, taking out and drying;
(5) putting the workpiece into a serum solution for soaking for 12 hours, taking out and drying;
(6) the member was immersed in a plasma solution containing hematopoietic stem cells for 2 hours to obtain a PEEK bionic bone member having a multilayer structure of the present example.
Example 2
The PEEK bionic bone part with the multilayer structure is a human tibia bionic part, and the structure of the PEEK bionic bone part is shown in fig. 1, and the PEEK bionic bone part sequentially comprises a periosteum layer, a bone dense layer, a bone loose layer and a bone marrow cavity from outside to inside and is consistent with the structure of a human tibia.
The preparation method comprises the following steps:
(1) putting 28g of PEEK powder and 2g of PTFE powder into a container, adding 4.0g of calcium carbonate whiskers and 0.12g of sulfonated PEEK (the sulfonation degree is 90%) into the PEEK and PTFE powder, continuously stirring for 24h, adding 2.0g of silk fibroin modified hydroxyapatite, continuously stirring for 12h, adding 0.03g of sodium bicarbonate and 0.003g of azodicarbonamide, and continuously stirring for 30min to obtain a raw material mixture of the periosteum layer;
putting 28g of PEEK powder and 2g of PTFE powder into a container, adding 4.0g of calcium carbonate whiskers and 0.12g of sulfonated PEEK (the sulfonation degree is 90%) into the PEEK and PTFE powder, continuously stirring for 24h, adding 2.0g of silk fibroin modified hydroxyapatite, continuously stirring for 12h, adding 0.09g of sodium bicarbonate and 0.01g of azodicarbonamide, and continuously stirring for 30min to obtain a bone compact layer raw material mixture;
putting 28g of PEEK powder and 2g of PTFE powder into a container, adding 4.0g of calcium carbonate whiskers and 0.12g of sulfonated PEEK (the sulfonation degree is 90%) into the PEEK and PTFE powder, continuously stirring for 24h, adding 2.0g of silk fibroin modified hydroxyapatite, continuously stirring for 12h, adding 0.9g of sodium bicarbonate and 0.02g of azodicarbonamide, and continuously stirring for 30min to obtain a bone loose layer raw material mixture;
The silk fibroin modified hydroxyapatite is obtained by the following method: soaking nanometer hydroxyapatite in 3% silk fibroin solution for 30min, filtering, and oven drying at 80 deg.C.
(2) Respectively adding the periosteum layer raw material mixture, the compact bone layer raw material mixture and the bone loose layer raw material mixture into corresponding cavities of a 350-DEG C hot-pressing die, reacting for 15min under 30MPa, cooling the die to 170 ℃ by water, opening the die, and taking out a finished piece;
(3) putting the workpiece into a furnace, keeping the temperature at 110 ℃ for 12h, taking out the workpiece, and cooling the workpiece to room temperature;
(4) putting the workpiece into flowing clear water for washing for 8 hours, taking out and drying;
(5) putting the workpiece into a serum solution for soaking for 12 hours, taking out and drying;
(6) the member was immersed in a plasma solution containing hematopoietic stem cells for 2 hours to obtain a PEEK bionic bone member having a multilayer structure of the present example.
Example 3
The PEEK bionic bone part with the multilayer structure is a human tibia bionic part, and the structure of the PEEK bionic bone part is shown in fig. 1, and the PEEK bionic bone part sequentially comprises a periosteum layer, a bone dense layer, a bone loose layer and a bone marrow cavity from outside to inside and is consistent with the structure of a human tibia.
The preparation method comprises the following steps:
(1) putting 28g of PEEK powder and 2g of PTFE powder into a container, adding 4.8g of calcium carbonate whiskers and 0.144g of sulfonated PEEK (the sulfonation degree is 99.6%) into the PEEK and PTFE powder, continuously stirring for 24h, adding 2.4g of silk fibroin modified hydroxyapatite, continuously stirring for 12h, adding 0.03g of sodium bicarbonate and 0.003g of azodicarbonamide, and continuously stirring for 30min to obtain an periosteum raw material mixture;
Putting 28g of PEEK powder and 2g of PTFE powder into a container, adding 4.8g of calcium carbonate whiskers and 0.144g of sulfonated PEEK (the sulfonation degree is 99.6%) into the PEEK and PTFE powder, continuously stirring for 24h, adding 2.4g of silk fibroin modified hydroxyapatite, continuously stirring for 12h, adding 0.09g of sodium bicarbonate and 0.01g of azodicarbonamide, and continuously stirring for 30min to obtain a raw material mixture of the compact bone layer;
putting 28g of PEEK powder and 2g of PTFE powder into a container, adding 4.8g of calcium carbonate whiskers and 0.144g of sulfonated PEEK (the sulfonation degree is 99.6%) into the PEEK and PTFE powder, continuously stirring for 24h, adding 2.4g of silk fibroin modified hydroxyapatite, continuously stirring for 12h, adding 0.9g of sodium bicarbonate and 0.02g of azodicarbonamide, and continuously stirring for 30min to obtain a bone pine layer raw material mixture;
the silk fibroin modified hydroxyapatite is obtained by the following method: soaking nanometer hydroxyapatite in 3% silk fibroin solution for 30min, filtering, and oven drying at 80 deg.C.
(2) Respectively adding the periosteum layer raw material mixture, the compact bone layer raw material mixture and the bone loose layer raw material mixture into corresponding cavities of a 360-DEG C hot-pressing die, reacting for 10min under 45MPa, cooling the die to 180℃ by water, opening the die, and taking out a finished piece;
(3) Putting the workpiece into a furnace, keeping the temperature at 110 ℃ for 14h, taking out the workpiece, and cooling the workpiece to room temperature;
(4) putting the workpiece into flowing clear water for washing for 10 hours, taking out and drying;
(5) putting the workpiece into a serum solution for soaking for 12 hours, taking out and drying;
(6) the member was immersed in a plasma solution containing hematopoietic stem cells for 2 hours to obtain a PEEK bionic bone member having a multilayer structure of the present example.
The slices of the human tibial bionic parts prepared in the embodiments 1 to 3 are taken and observed under an electron microscope, wherein the observation results of the slices of the human tibial bionic part in the embodiment 1 are shown in fig. 2a, fig. 2b and fig. 2 c.
As can be seen from fig. 2a, the periosteum layer with the foaming agent content of 0.1% has relatively low porosity and relatively small pore diameter, the section also presents a smooth spherical bubble structure, the compactness of the matrix is high, and the gaps basically present a discontinuous spatial structure; as can be seen from fig. 2b, the porosity of the compact bone layer with 0.5% of foaming agent relative to the periosteum material is increased (the porosity of the compact bone layer is 10-15%), the pore diameter is also increased, the connectivity among the pores begins to appear, and the three-dimensional communication structure between the layers is more obvious; as can be seen from FIG. 2c, the spongy layer material with a foaming agent content of 3% has the largest pore size and larger porosity (the porosity of the spongy layer is 36-44%), and the cells are effectively communicated with each other, and meanwhile, irregular overlapping of the large pores and the small pores appears, and the spongy layer material shows consistency with the solid bone structure.
The human tibia bionic workpiece prepared in the embodiment 1-3 is taken, and the Poisson's ratio (namely, transverse deformation coefficient) of the material is detected on a ZWICK Z050 material biaxial mechanical property testing machine, wherein the test conditions are as follows: room temperature, design cuboid style size: 15mm multiplied by 10mm, displacement control is adopted for loading, the loading rate is set to be 0.2mm/min, the compressive strain and the axial strain when the compression is carried out for 2min are measured, and then the Poisson ratio is calculated. The results are shown in Table 1.
TABLE 1 Poisson ratio test results (compression) of human tibial biomimetic fabricated parts prepared in examples
Example 1 Example 2 Example 3
Poisson's ratio 0.328 0.358 0.376
The human tibial bionic parts prepared in the embodiments 1 to 3 are taken, and the volume abrasion loss and the friction coefficient of each part are detected. The friction wear test is carried out on an MM-200 type wear testing machine (Jinan), an open boundary lubrication wear mode is adopted, the deproteinized calf serum injection is lubricated, the dropping amount is 20 drops/min, an upper test sample (a sample for the test) is in reciprocating horizontal movement, the movement frequency is 16 times/min, and the displacement is 1 MM; the rotational speed of the lower sample (bone material) was 200 rad/min.
The wear resistance of the sample is measured by the volume wear loss, the width of the grinding mark is measured by a 10-time reading microscope, each grinding mark is measured for 5 times, and the width of the grinding mark is obtained by averaging. The volumetric wear amount was calculated by the following formula:
Figure GDA0003449036020000111
In the formula: v represents the wear volume, B represents the width of the lower sample of 10mm, B represents the width of the wear scar, and r represents the radius of the lower sample of 20 mm.
The friction torque of the friction pair was measured using a friction torque scale of 1000N · mm, and the friction coefficient was calculated by the following formula:
Figure GDA0003449036020000112
in the formula: μ represents the coefficient of friction, T represents the friction torque (N · m), R represents the lower specimen radius of 0.02m, and P represents the vertical load (N) to which the specimen is subjected.
The results are shown in Table 2.
TABLE 2 results of measurements of volume wear and friction coefficient of bionic human tibia parts in each example
Example 1 Example 2 Example 3
Volume wear amount 0.0018g/day 0.0013g/day 0.0007g/day
Coefficient of friction 0.123 0.114 0.086
Comparative example 1
The PEEK bionic bone part with a multilayer structure in this embodiment has the same manufacturing method as that in embodiment 1, but the foaming agent adopted in the raw materials of the bone loose layer is: 0.09g of sodium bicarbonate and 0.018g of azodicarbonamide.
Comparative example 2
The PEEK bionic bone part with a multilayer structure in this embodiment has the same manufacturing method as that in embodiment 1, but the foaming agent adopted in the raw materials of the bone loose layer is: 0.05g of sodium bicarbonate and 0.05g of azodicarbonamide.
Comparative example 3
The PEEK bionic bone part with a multilayer structure in this embodiment has the same manufacturing method as that in embodiment 1, but the foaming agent adopted in the raw materials of the bone loose layer is: 0.01g of sodium bicarbonate and 0.09g of azodicarbonamide.
Comparative example 4
The PEEK bionic bone part with a multilayer structure in this embodiment has the same manufacturing method as that in embodiment 1, but the foaming agent adopted in the raw materials of the bone loose layer is: 0.1g sodium bicarbonate.
Comparative example 5
The PEEK bionic bone part with a multilayer structure in this embodiment has the same manufacturing method as that in embodiment 1, but the foaming agent adopted in the raw materials of the bone loose layer is: 0.1g azodicarbonamide.
The average porosity of the bone cancellous layer of the PEEK simulated bone parts obtained in example 1 and comparative examples 1 to 5 was measured, and the results are shown in table 3.
TABLE 3
Examples Foaming agent Average porosity
Example 1 Sodium bicarbonate and azodicarbonamide 45:1 40%
Comparative example 1 Sodium bicarbonate and azodicarbonamide 5:1 25%
Comparative example 2 Sodium bicarbonate and azodicarbonamide 1:1 12%
Comparative example 3 Sodium bicarbonate and azodicarbonamide 1:9 9%
Comparative example 4 Sodium bicarbonate alone 18%
Comparative example 5 Azodicarbonamide only 11%

Claims (9)

1.一种多孔PEEK仿生骨修复材料,其特征在于,按质量份数计,原料组成包括基体材料100份、增强材料12-16份、发泡剂0.1-3份和生物活性物质0.1-0.5份;1. a porous PEEK biomimetic bone repair material, is characterized in that, in parts by mass, the raw material composition comprises 100 parts of matrix materials, 12-16 parts of reinforcing materials, 0.1-3 parts of foaming agents and 0.1-0.5 parts of bioactive substances share; 所述的基体材料包括质量比为14:1的医用PEEK粉末和医用PTFE粉末;The base material includes medical PEEK powder and medical PTFE powder with a mass ratio of 14:1; 所述的增强材料包括丝素蛋白改性的纳米羟基磷灰石和磺化PEEK改性的碳酸钙晶须;The reinforcing material includes silk fibroin-modified nano-hydroxyapatite and sulfonated PEEK-modified calcium carbonate whiskers; 所述的多孔PEEK仿生骨修复材料由以下方法制备获得:The porous PEEK bionic bone repair material is prepared by the following method: (1)按预设的原料组成,将PTFE粉末和增强材料添加到PEEK粉末中,连续搅拌24h后加入发泡剂,继续搅拌1~2h,获得原料混合物;(1) According to the preset raw material composition, add PTFE powder and reinforcing material to PEEK powder, add foaming agent after continuous stirring for 24 hours, and continue stirring for 1-2 hours to obtain a raw material mixture; (2)预制人胫骨模具并预热至220℃,将原料混合物添加到相应的模具腔内,然后升温至340-360℃,在25-40MPa热压下反应10-15min,将模具水冷至160-180℃开模,取出制件;(2) Pre-fabricate a human tibia mold and preheat to 220°C, add the raw material mixture into the corresponding mold cavity, then heat up to 340-360°C, react under 25-40MPa hot pressing for 10-15min, and cool the mold to 160°C Open the mold at -180℃ and take out the part; (3)将制件放入110-130℃下保温10-14h,取出后冷却至室温;(3) Put the product into the temperature of 110-130℃ for 10-14h, take it out and cool it to room temperature; (4)将制件放入流动的清水中冲洗6-10h,取出后烘干;(4) Put the parts into flowing clean water to rinse for 6-10h, take them out and dry them; (5)将制件放入含有诱导原液的血清中浸泡12h,取出后烘干;(5) Put the part into the serum containing the induction stock solution and soak it for 12h, take it out and dry it; (6)将制件放入含有间充质干细胞的血浆中浸泡2h,获得所述的多孔PEEK仿生骨修复材料。(6) Soak the product in plasma containing mesenchymal stem cells for 2 hours to obtain the porous PEEK biomimetic bone repair material. 2.如权利要求1所述的多孔PEEK仿生骨修复材料,其特征在于,所述的发泡剂为质量比为9:1的碳酸氢钠和偶氮二甲酰胺。2. The porous PEEK bionic bone repair material according to claim 1, wherein the foaming agent is sodium bicarbonate and azodicarbonamide in a mass ratio of 9:1. 3.如权利要求1所述的多孔PEEK仿生骨修复材料,其特征在于,所述的增强材料包括质量比为3:7的丝素蛋白改性的纳米羟基磷灰石和磺化PEEK改性的碳酸钙晶须。3. The porous PEEK biomimetic bone repair material according to claim 1, wherein the reinforcing material comprises silk fibroin-modified nano-hydroxyapatite and sulfonated PEEK modified in a mass ratio of 3:7 of calcium carbonate whiskers. 4.如权利要求3所述的多孔PEEK仿生骨修复材料,其特征在于,所述的丝素蛋白改性的纳米羟基磷灰石由将纳米羟基磷灰石浸泡在浓度为3%的丝素蛋白溶液中20-40min后获得;4. The porous PEEK biomimetic bone repair material according to claim 3, wherein the silk fibroin-modified nano-hydroxyapatite is prepared by soaking the nano-hydroxyapatite in silk fibroin with a concentration of 3%. Obtained after 20-40min in protein solution; 所述的磺化PEEK改性的碳酸钙晶须由质量比为100:3的碳酸钙晶须与磺化PEEK混合后交联获得,该磺化PEEK的磺化度为84.0-99.6%。The sulfonated PEEK-modified calcium carbonate whiskers are obtained by mixing calcium carbonate whiskers with a mass ratio of 100:3 and sulfonated PEEK and then cross-linking, and the sulfonation degree of the sulfonated PEEK is 84.0-99.6%. 5.如权利要求1所述的多孔PEEK仿生骨修复材料,其特征在于,所述的生物活性物质为:含有诱导原液的血清以及含有间充质干细胞的血浆;5. The porous PEEK biomimetic bone repair material according to claim 1, wherein the biologically active substances are: serum containing induced stock solution and plasma containing mesenchymal stem cells; 血清中诱导原液的浓度为0.12-0.14%,血浆中间充质干细胞的浓度为1.6-2.0%。The concentration of the induced stock solution in serum was 0.12-0.14%, and the concentration of mesenchymal stem cells in plasma was 1.6-2.0%. 6.一种具有多层结构的PEEK仿生骨制件,其特征在于,每层结构均采用如权利要求1-5中任意一项所述的多孔PEEK仿生骨修复材料制成,自PEEK仿生骨制件的外侧向中心,各层结构的原料组成中发泡剂的含量逐渐增加。6. A PEEK biomimetic bone product with a multi-layer structure is characterized in that, each layer structure is made of the porous PEEK biomimetic bone repair material described in any one of claims 1-5, and is made from PEEK biomimetic bone. From the outer side of the part to the center, the content of the foaming agent in the raw material composition of each layer structure gradually increases. 7.如权利要求6所述的具有多层结构的PEEK仿生骨制件,其特征在于,为人胫骨仿生制件,该人胫骨仿生制件由外至内依次包括骨膜层(1)、骨密质层(2)、骨松质层(3)和骨髓腔(4),所述的骨膜层(1)的厚度为0.2mm,所述的骨密质层(2)的孔隙率为10~15%,所述的骨松质层(3)的孔隙率为45~60%,骨髓腔(4)的直径为6~12mm。7. The PEEK biomimetic bone part with a multi-layer structure as claimed in claim 6, characterized in that it is a human tibia biomimetic part, and the human tibia biomimetic part sequentially comprises a periosteum layer (1), a bone density from outside to inside The stromal layer (2), the cancellous bone layer (3) and the bone marrow cavity (4), the thickness of the periosteum layer (1) is 0.2 mm, and the porosity of the cortical bone layer (2) is 10-10 mm. 15%, the porosity of the cancellous bone layer (3) is 45-60%, and the diameter of the bone marrow cavity (4) is 6-12 mm. 8.如权利要求7所述的具有多层结构的PEEK仿生骨制件,其特征在于,按质量份数计,所述的骨膜层(1)的原料组成包括基体材料100份、增强材料12-16份、发泡剂0.1份和生物活性物质0.1-0.3份;8. The PEEK biomimetic bone part with a multi-layer structure according to claim 7, characterized in that, in parts by mass, the raw material composition of the periosteum layer (1) comprises 100 parts of a matrix material, 12 parts of a reinforcing material -16 parts, 0.1 part of foaming agent and 0.1-0.3 part of biological active substance; 所述的骨密质层(2)的原料组成包括基体材料100份、增强材料12-16份、发泡剂0.5份和生物活性物质0.3-0.5份;The raw material composition of the compact bone layer (2) includes 100 parts of base material, 12-16 parts of reinforcing material, 0.5 part of foaming agent and 0.3-0.5 part of biological active substance; 所述的骨松质层(3)的原料组成包括基体材料100份、增强材料12-16份、发泡剂3份和生物活性物质0.3-0.5份。The raw material composition of the cancellous bone layer (3) includes 100 parts of matrix material, 12-16 parts of reinforcing material, 3 parts of foaming agent and 0.3-0.5 part of biological active substance. 9.如权利要求6-8中任意一项所述的具有多层结构的PEEK仿生骨制件的制备方法,其特征在于,包括以下步骤:9. the preparation method of the PEEK biomimetic bone product with multilayer structure as described in any one of claim 6-8, is characterized in that, comprises the following steps: (1)按预设的原料组成,将PTFE粉末和增强材料添加到PEEK粉末中,连续搅拌24h后加入发泡剂,继续搅拌1~2h,分别获得骨膜层原料混合物、骨密质层原料混合物和骨松质层原料混合物;(1) According to the preset raw material composition, add PTFE powder and reinforcing material to PEEK powder, add foaming agent after continuous stirring for 24 hours, and continue stirring for 1-2 hours to obtain the periosteal layer raw material mixture and the bone compact layer raw material mixture respectively. and cancellous layer raw material mixture; (2)预制人胫骨模具并预热至220℃,将骨膜层原料混合物、骨密质层原料混合物和骨松质层原料混合物分别添加到相应的模具腔内,然后升温至340-360℃,在25-40MPa热压下反应10-15min,将模具水冷至160-180℃开模,取出制件;(2) Prefabricating a human tibia mold and preheating to 220°C, adding the periosteal layer raw material mixture, the compact bone layer raw material mixture and the cancellous bone layer raw material mixture to the corresponding mold cavity, and then heating to 340-360°C, React under 25-40MPa hot pressure for 10-15min, cool the mold to 160-180℃, open the mold, and take out the part; (3)将制件放入110-130℃下保温10-14h,取出后冷却至室温;(3) Put the product into the temperature of 110-130℃ for 10-14h, take it out and cool it to room temperature; (4)将制件放入流动的清水中冲洗6-10h,取出后烘干;(4) Put the parts into flowing clean water for 6-10 hours, take them out and dry them; (5)将制件放入含有诱导原液的血清中浸泡12h,取出后烘干;(5) Put the part into the serum containing the induction stock solution and soak it for 12h, take it out and dry it; (6)将制件放入含有间充质干细胞的血浆中浸泡2h,获得所述的具有多层结构的PEEK仿生骨制件。(6) Soak the product in plasma containing mesenchymal stem cells for 2 hours to obtain the PEEK biomimetic bone product with a multi-layer structure.
CN201910779682.3A 2019-08-22 2019-08-22 Porous PEEK (polyetheretherketone) bionic bone repair material, PEEK bionic bone part with multilayer structure and preparation method thereof Active CN110876817B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910779682.3A CN110876817B (en) 2019-08-22 2019-08-22 Porous PEEK (polyetheretherketone) bionic bone repair material, PEEK bionic bone part with multilayer structure and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910779682.3A CN110876817B (en) 2019-08-22 2019-08-22 Porous PEEK (polyetheretherketone) bionic bone repair material, PEEK bionic bone part with multilayer structure and preparation method thereof

Publications (2)

Publication Number Publication Date
CN110876817A CN110876817A (en) 2020-03-13
CN110876817B true CN110876817B (en) 2022-03-04

Family

ID=69727432

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910779682.3A Active CN110876817B (en) 2019-08-22 2019-08-22 Porous PEEK (polyetheretherketone) bionic bone repair material, PEEK bionic bone part with multilayer structure and preparation method thereof

Country Status (1)

Country Link
CN (1) CN110876817B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113754918B (en) * 2021-09-29 2022-11-08 复旦大学 Surface-modified polyether-ether-ketone material and preparation method and application thereof
CN114601975B (en) * 2022-04-02 2022-12-06 奥精医疗科技股份有限公司 Polyether-ether-ketone composite mineralized collagen material as well as preparation method and application thereof

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1438104A (en) * 2003-03-21 2003-08-27 湖北大学 Method for making microporous foamed engineering plastic by mould pressing
WO2009095960A1 (en) * 2008-01-28 2009-08-06 Ngk Spark Plug Co., Ltd. Surface foamed article, biological implant and method of producing the same
CN102058906A (en) * 2010-11-24 2011-05-18 南京理工大学 Nanoparticle-reinforced polyether-ether-ketone joint prosthesis material as well as preparation method and application thereof
CN104524637A (en) * 2014-06-03 2015-04-22 东莞天天向上医疗科技有限公司 Polymer bioceramic composite nanoparticle biodegradable scaffold and manufacturing method thereof
CN107224615A (en) * 2016-03-25 2017-10-03 文阳洋 A kind of artificial bionic bone and its synthetic method
CN107541012A (en) * 2017-08-16 2018-01-05 宜宾天原集团股份有限公司 A kind of high-performance fiber reinforced polyether ether ketone composite-material formula and preparation method thereof
CN107823712A (en) * 2017-12-13 2018-03-23 华中科技大学 A kind of method for preparing imitative artificial bone of coral with cuttlebone and products thereof
CN107857891A (en) * 2017-09-30 2018-03-30 中国科学院长春应用化学研究所 The preparation method of polymer foams
CN108273137A (en) * 2018-01-02 2018-07-13 山东百多安医疗器械有限公司 A kind of porous bionical material for repairing skull and personalized production method
CN108622893A (en) * 2018-03-29 2018-10-09 深圳大学 A kind of preparation method and porous carbon materials of porous carbon materials
CN109276760A (en) * 2018-09-04 2019-01-29 南宁越洋科技有限公司 The preparation method of PEEK Polysulfone Composite Hip Prosthesis suitable for 3D printing
CN109641375A (en) * 2016-08-25 2019-04-16 巴斯夫欧洲公司 Microwave foaming

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL153699A (en) * 2002-12-26 2008-11-26 Prochon Biotech Ltd Bone graft composite
CN100522559C (en) * 2008-02-22 2009-08-05 四川大学 Method of semi-vitreous extrusion molding manufacturing for portiforium type millipore plastics extrusions
CN105061990B (en) * 2015-09-28 2017-06-16 吉林大学 A kind of sulfonation hyperbranched polyarylether ketone modified calcium carbonate whisker/polyether-ether-ketone composite material and preparation method thereof

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1438104A (en) * 2003-03-21 2003-08-27 湖北大学 Method for making microporous foamed engineering plastic by mould pressing
WO2009095960A1 (en) * 2008-01-28 2009-08-06 Ngk Spark Plug Co., Ltd. Surface foamed article, biological implant and method of producing the same
US9931438B2 (en) * 2008-01-28 2018-04-03 Ngk Spark Plug Co., Ltd. Article with foamed surface, implant and method of producing the same
CN102058906A (en) * 2010-11-24 2011-05-18 南京理工大学 Nanoparticle-reinforced polyether-ether-ketone joint prosthesis material as well as preparation method and application thereof
CN104524637A (en) * 2014-06-03 2015-04-22 东莞天天向上医疗科技有限公司 Polymer bioceramic composite nanoparticle biodegradable scaffold and manufacturing method thereof
CN107224615A (en) * 2016-03-25 2017-10-03 文阳洋 A kind of artificial bionic bone and its synthetic method
CN109641375A (en) * 2016-08-25 2019-04-16 巴斯夫欧洲公司 Microwave foaming
CN107541012A (en) * 2017-08-16 2018-01-05 宜宾天原集团股份有限公司 A kind of high-performance fiber reinforced polyether ether ketone composite-material formula and preparation method thereof
CN107857891A (en) * 2017-09-30 2018-03-30 中国科学院长春应用化学研究所 The preparation method of polymer foams
CN107823712A (en) * 2017-12-13 2018-03-23 华中科技大学 A kind of method for preparing imitative artificial bone of coral with cuttlebone and products thereof
CN108273137A (en) * 2018-01-02 2018-07-13 山东百多安医疗器械有限公司 A kind of porous bionical material for repairing skull and personalized production method
CN108622893A (en) * 2018-03-29 2018-10-09 深圳大学 A kind of preparation method and porous carbon materials of porous carbon materials
CN109276760A (en) * 2018-09-04 2019-01-29 南宁越洋科技有限公司 The preparation method of PEEK Polysulfone Composite Hip Prosthesis suitable for 3D printing

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
In vivo bioactivity of porous polyetheretherketone with a foamed surface;Hieda, Ayato等;《DENTAL MATERIALS JOURNAL》;20170430;第36卷(第2期);222-229 *
高性能聚芳醚酮泡沫材料的制备与性能研究;王辉;《中国博士学位论文全文数据库工程科技Ⅰ辑》;20130830;B016-155 *

Also Published As

Publication number Publication date
CN110876817A (en) 2020-03-13

Similar Documents

Publication Publication Date Title
Feng et al. Application of 3D printing technology in bone tissue engineering: a review
Baino et al. Bioceramics and scaffolds: a winning combination for tissue engineering
Deb et al. Scaffold development using biomaterials: a review
CN101549175B (en) Method for preparation of pore heterogeneous distribution bionic bone material
CN1209170C (en) Porous synthetic bone graft and method of manufacture thereof
Kim et al. Gas foaming fabrication of porous biphasic calcium phosphate for bone regeneration
CN108273137A (en) A kind of porous bionical material for repairing skull and personalized production method
JP3817267B2 (en) Porous material products
CN110876817B (en) Porous PEEK (polyetheretherketone) bionic bone repair material, PEEK bionic bone part with multilayer structure and preparation method thereof
CN112402701A (en) Diagnosis and treatment integrated gradient osteochondral bionic scaffold and preparation method thereof
CN104941000A (en) Method for preparing alveolar bone scaffold by three-dimensional printing
CN102671236A (en) Method for preparing nanofiber reinforcement hydrogel bionic artificial meniscus composite material
CN108404214A (en) A kind of bionical osteochondral composites and preparation method thereof
CN112220964A (en) Composite biological ceramic powder, composite biological ceramic artificial bone prepared from composite biological ceramic powder and preparation method of composite biological ceramic artificial bone
EP2897655A1 (en) Scaffold with cortical wall
CN116059442A (en) Repairing material with polyether-ether-ketone as matrix and preparation method and application thereof
AU2020224769A1 (en) Reinforced biocompatible scaffold
CN107050513A (en) A kind of gradient dip-coating HA prepares ZrO2The method of Bone Defect Repari bioceramic scaffold material
EP2897657A1 (en) Hard scaffold
CN104708736A (en) Modified polyvinyl alcohol hydrogel material, special die, preparation method and application
CN108578780A (en) A kind of preparation method of artificial bone scaffold of the carrying silver ion with mechanical gradient
CN104984413B (en) Preparation method of bionic tissue engineering osteochondral integrated scaffold containing calcified layer
CN106270516A (en) The preparation method of double gradient porous NiTi/ hydroxyapatite composite materials
RU2349289C1 (en) Composition, bioactive microporous material imitating natural osseous structures, and method of manufacturing
Softas Selective Laser Sintering of Hydroxyapatite-Based Materials for Tissue Engineering

Legal Events

Date Code Title Description
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant